{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:48:44Z","timestamp":1761662924141},"reference-count":101,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T00:00:00Z","timestamp":1295481600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0014548","type":"journal-article","created":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T21:50:04Z","timestamp":1295560204000},"page":"e14548","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Evolutionary and Structural Features of the C2, V3 and C3 Envelope Regions Underlying the Differences in HIV-1 and HIV-2 Biology and Infection"],"prefix":"10.1371","volume":"6","author":[{"given":"Helena","family":"Barroso","sequence":"first","affiliation":[]},{"given":"Pedro","family":"Borrego","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"B\u00e1rtolo","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Maria","family":"Marcelino","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Fam\u00edlia","sequence":"additional","affiliation":[]},{"given":"Alexandre","family":"Quintas","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Taveira","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2011,1,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1742-4690-7-25","article-title":"The role of recombination in the emergence of a complex and dynamic HIV epidemic.","volume":"7","author":"M Zhang","year":"2010","journal-title":"Retrovirology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1073\/pnas.0936469100","article-title":"Tracing the origin and history of the HIV-2 epidemic.","volume":"100","author":"P Lemey","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.tim.2008.09.003","article-title":"HIV-2: the forgotten AIDS virus.","volume":"16","author":"TI de Silva","year":"2008","journal-title":"Trends Microbiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/519387","article-title":"Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France.","volume":"196","author":"C Semaille","year":"2007","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1086\/597504","article-title":"20 years of HIV-2 infection in Portugal: trends and changes in epidemiology.","volume":"48","author":"E Valadas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1128\/JVI.68.11.7433-7447.1994","article-title":"Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology.","volume":"68","author":"F Gao","year":"1994","journal-title":"J Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1128\/JVI.71.5.3953-3960.1997","article-title":"Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys.","volume":"71","author":"Z Chen","year":"1997","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/08892220050042864","article-title":"Identification of a new HIV-2 subtype based on phylogenetic analysis of full-length genomic sequence.","volume":"16","author":"J Yamaguchi","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1089\/0889222041217392","article-title":"Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification.","volume":"20","author":"F Damond","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2217\/17460913.1.4.427","article-title":"Protective immunity against HIV infection: lessons from HIV-2 infection.","volume":"1","author":"S Rowland-Jones","year":"2006","journal-title":"Future Microbiol"},{"key":"ref11","first-page":"457","article-title":"Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection.","volume":"1","author":"N Berry","year":"1998","journal-title":"J Hum Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"12425","DOI":"10.1128\/JVI.01557-06","article-title":"Increased frequency of circulating CCR5+ CD4+ T cells in human immunodeficiency virus type 2 infection.","volume":"80","author":"R Soares","year":"2006","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1126\/science.7915856","article-title":"Reduced rate of disease development after HIV-2 infection as compared to HIV-1.","volume":"265","author":"R Marlink","year":"1994","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/QAD.0b013e3282f4ddfc","article-title":"Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.","volume":"22","author":"J Drylewicz","year":"2008","journal-title":"AIDS"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1128\/JVI.02789-06","article-title":"Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections.","volume":"81","author":"SK Rodriguez","year":"2007","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0042-6822(02)00088-0","article-title":"Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infection.","volume":"308","author":"Q Lizeng","year":"2003","journal-title":"Virology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1099\/vir.0.81259-0","article-title":"Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation.","volume":"86","author":"Y Shi","year":"2005","journal-title":"J Gen Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1006\/viro.1993.1160","article-title":"Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.","volume":"193","author":"E Bjorling","year":"1993","journal-title":"Virology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1097\/00002030-200012010-00007","article-title":"Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity.","volume":"14","author":"R Cavaleiro","year":"2000","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1002\/eji.200737511","article-title":"Monocyte-mediated T cell suppression by HIV-2 envelope proteins.","volume":"37","author":"R Cavaleiro","year":"2007","journal-title":"Eur J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm0402-319","article-title":"CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?","volume":"8","author":"Z Grossman","year":"2002","journal-title":"Nat Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virol.2006.05.029","article-title":"In vitro replication capacity of HIV-2 variants from long-term aviremic individuals.","volume":"353","author":"H Blaak","year":"2006","journal-title":"Virology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1128\/JVI.02625-06","article-title":"Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection.","volume":"81","author":"A MacNeil","year":"2007","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/31514","article-title":"The antigenic structure of the HIV gp120 envelope glycoprotein.","volume":"393","author":"R Wyatt","year":"1998","journal-title":"Nature"},{"key":"ref25","article-title":"Influence of Novel CD4 binding-defective HIV-1 Envelope Glycoprotein Immunogens on Neutralizing Antibody and T Cell Responses in Non-human Primates.","author":"I Douagi","year":"2009","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1128\/JVI.68.11.6836-6847.1994","article-title":"Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1.","volume":"68","author":"JP Moore","year":"1994","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.1905842","article-title":"Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.","volume":"253","author":"SS Hwang","year":"1991","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1126\/science.280.5371.1949","article-title":"A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.","volume":"280","author":"CD Rizzuto","year":"1998","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1073\/pnas.86.17.6768","article-title":"Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.","volume":"86","author":"K Javaherian","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1126\/science.1703322","article-title":"Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.","volume":"250","author":"K Javaherian","year":"1990","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1128\/JVI.02619-05","article-title":"Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1.","volume":"80","author":"CP Krachmarov","year":"2006","journal-title":"Journal of Virology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1128\/JVI.01743-08","article-title":"Human immunodeficiency virus type 2 (HIV-2)\/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma.","volume":"83","author":"KL Davis","year":"2009","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/COH.0b013e32832edc19","article-title":"Immunogenicity of HIV-1 envelope glycoprotein oligomers.","volume":"4","author":"MN Forsell","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nature07930","article-title":"Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.","volume":"458","author":"JF Scheid","year":"2009","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.","volume":"326","author":"LM Walker","year":"2009","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1089\/aid.1994.10.1659","article-title":"Characterization of monoclonal antibodies to human immunodeficiency virus type 2 envelope glycoproteins.","volume":"10","author":"F Traincard","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1073\/pnas.88.14.6082","article-title":"Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity.","volume":"88","author":"E Bjorling","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.4049\/jimmunol.152.4.1952","article-title":"Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2.","volume":"152","author":"E Bjorling","year":"1994","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1128\/JVI.70.7.4598-4606.1996","article-title":"Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein.","volume":"70","author":"A McKnight","year":"1996","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-1702(98)00133-6","article-title":"Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2.","volume":"59","author":"A Morner","year":"1999","journal-title":"Virus Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1128\/JVI.69.6.3333-3340.1995","article-title":"Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120.","volume":"69","author":"S Matsushita","year":"1995","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"12429","DOI":"10.1128\/JVI.01102-10","article-title":"Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy.","volume":"84","author":"JM Marcelino","year":"2010","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1128\/JCM.39.10.3803-3807.2001","article-title":"V3 serological subtyping of human immunodeficiency virus type 2 infection is not relevant.","volume":"39","author":"JC Plantier","year":"2001","journal-title":"J Clin Microbiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/QAD.0b013e3283155546","article-title":"Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression.","volume":"22","author":"JM Marcelino","year":"2008","journal-title":"AIDS"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/JCM.44.2.607-611.2006","article-title":"Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins.","volume":"44","author":"JM Marcelino","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1128\/JVI.65.9.5073-5079.1991","article-title":"Localization of immunogenic domains in the human immunodeficiency virus type 2 envelope.","volume":"65","author":"ML Huang","year":"1991","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"18514","DOI":"10.1073\/pnas.0504658102","article-title":"Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection.","volume":"102","author":"SD Frost","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","first-page":"125","article-title":"HIV evolutionary dynamics within and among hosts.","volume":"8","author":"P Lemey","year":"2006","journal-title":"AIDS Rev"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1139\/o06-143","article-title":"QUASI analysis of the HIV-1 envelope sequences in the Los Alamos National Laboratory HIV sequence database: pattern and distribution of positive selection sites and their frequencies over years.","volume":"85","author":"B Liang","year":"2007","journal-title":"Biochem Cell Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-4690-6-4","article-title":"Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjects.","volume":"6","author":"F Canducci","year":"2009","journal-title":"Retrovirology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1128\/JCM.41.7.3361-3367.2003","article-title":"Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms.","volume":"41","author":"R Antunes","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1742-4690-5-78","article-title":"The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.","volume":"5","author":"P Borrego","year":"2008","journal-title":"Retrovirology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/088922202753519089","article-title":"Molecular epidemiology of HIV type 1 infection in Portugal: high prevalence of non-B subtypes.","volume":"18","author":"A Esteves","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.meegid.2007.01.009","article-title":"Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal.","volume":"7","author":"AC Palma","year":"2007","journal-title":"Infect Genet Evol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1128\/JVI.68.11.7467-7481.1994","article-title":"Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences.","volume":"68","author":"BT Korber","year":"1994","journal-title":"J Virol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1128\/JVI.66.11.6777-6780.1992","article-title":"Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution.","volume":"66","author":"JJ De Jong","year":"1992","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/viro.2001.1087","article-title":"Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks.","volume":"288","author":"W Resch","year":"2001","journal-title":"Virology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/viro.1999.0006","article-title":"Small amino acid changes in the V3 loop of human immunodeficiency virus type 2 determines the coreceptor usage for CXCR4 and CCR5.","volume":"264","author":"Y Isaka","year":"1999","journal-title":"Virology"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1128\/JVI.02548-09","article-title":"HIV-2 genetic evolution in patients with advanced disease is faster than in matched HIV-1 patients.","volume":"84","author":"H Skar","year":"2010","journal-title":"J Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.","volume":"393","author":"PD Kwong","year":"1998","journal-title":"Nature"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<111::AID-JMV18>3.0.CO;2-W","article-title":"Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load.","volume":"61","author":"V Soriano","year":"2000","journal-title":"J Med Virol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.meegid.2004.07.008","article-title":"Evidence for negative selective pressure in HIV-2 evolution in vivo.","volume":"5","author":"H Barroso","year":"2005","journal-title":"Infect Genet Evol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature05580","article-title":"Structural definition of a conserved neutralization epitope on HIV-1 gp120.","volume":"445","author":"T Zhou","year":"2007","journal-title":"Nature"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/JVI.02187-07","article-title":"The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection.","volume":"82","author":"PL Moore","year":"2008","journal-title":"J Virol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1128\/JVI.00257-07","article-title":"Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1.","volume":"81","author":"R Rong","year":"2007","journal-title":"J Virol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.1070441","article-title":"Diversity considerations in HIV-1 vaccine selection.","volume":"296","author":"B Gaschen","year":"2002","journal-title":"Science"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1128\/JVI.78.4.1962-1970.2004","article-title":"Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes.","volume":"78","author":"M Choisy","year":"2004","journal-title":"J Virol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1371\/journal.pcbi.0020062","article-title":"Adaptation to different human populations by HIV-1 revealed by codon-based analyses.","volume":"2","author":"SL Pond","year":"2006","journal-title":"PLoS Comput Biol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/molbev\/msm001","article-title":"Phylogenetic evidence for deleterious mutation load in RNA viruses and its contribution to viral evolution.","volume":"24","author":"OG Pybus","year":"2007","journal-title":"Mol Biol Evol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1126\/science.1093137","article-title":"Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.","volume":"303","author":"CA Derdeyn","year":"2004","journal-title":"Science"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1371\/journal.pcbi.0030029","article-title":"Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics.","volume":"3","author":"P Lemey","year":"2007","journal-title":"PLoS Comput Biol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.1118398","article-title":"Structure of a V3-containing HIV-1 gp120 core.","volume":"310","author":"CC Huang","year":"2005","journal-title":"Science"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2174\/157016207782418470","article-title":"Roles of HIV-1 Env variable regions in viral neutralization and vaccine development.","volume":"5","author":"A Pinter","year":"2007","journal-title":"Curr HIV Res"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/COH.0b013e32832e06fe","article-title":"Specificities of broadly neutralizing anti-HIV-1 sera.","volume":"4","author":"J Binley","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/COH.0b013e32832f00c0","article-title":"HIV-1-specific antibody responses during acute and chronic HIV-1 infection.","volume":"4","author":"GD Tomaras","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/aid.2007.0158","article-title":"Focused dampening of antibody response to the immunodominant variable loops by engineered soluble gp140.","volume":"24","author":"S Selvarajah","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4049\/jimmunol.159.1.279","article-title":"Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope.","volume":"159","author":"RR Garrity","year":"1997","journal-title":"J Immunol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/viro.2002.1727","article-title":"Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies.","volume":"305","author":"YB Kim","year":"2003","journal-title":"Virology"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/vim.1999.12.79","article-title":"Characterization of neutralizing sites in the second variable and fourth variable region in gp125 and a conserved region in gp36 of human immunodeficiency virus type 2.","volume":"12","author":"P Skott","year":"1999","journal-title":"Viral Immunol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1097\/00002030-200112070-00018","article-title":"Perinatally acquired HIV-2 infection diagnosed at 15 and 24 years of age.","volume":"15","author":"A Mota-Miranda","year":"2001","journal-title":"AIDS"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/viro.1995.1237","article-title":"Biological and molecular characterization of subtype D, G, and A\/D recombinant HIV-1 transmissions in Sweden.","volume":"209","author":"T Leitner","year":"1995","journal-title":"Virology"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1093\/nar\/25.24.4876","article-title":"The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.","volume":"25","author":"JD Thompson","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/bioinformatics\/14.9.817","article-title":"MODELTEST: testing the model of DNA substitution.","volume":"14","author":"D Posada","year":"1998","journal-title":"Bioinformatics"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-5193(05)80104-3","article-title":"The general stochastic model of nucleotide substitution.","volume":"142","author":"F Rodriguez","year":"1990","journal-title":"J Theor Biol"},{"key":"ref85","first-page":"6.5.1","article-title":"Using Modeltest and PAUP* to select a model of nucleotide substitution.","author":"D Posada","year":"2003"},{"key":"ref86","article-title":"PAUP*. Phylogenetic Analysis using Parsimony (*and other Methods). Version 4. Version 4 ed.","author":"DL Swofford","year":"1998"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/molbev\/msl051","article-title":"Automated phylogenetic detection of recombination using a genetic algorithm.","volume":"23","author":"SL Kosakovsky Pond","year":"2006","journal-title":"Mol Biol Evol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1093\/bioinformatics\/bti320","article-title":"Datamonkey: rapid detection of selective pressure on individual sites of codon alignments.","volume":"21","author":"SL Pond","year":"2005","journal-title":"Bioinformatics"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/glycob\/cwh106","article-title":"Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin.","volume":"14","author":"M Zhang","year":"2004","journal-title":"Glycobiology"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/bioinformatics\/bti079","article-title":"HyPhy: hypothesis testing using phylogenies.","volume":"21","author":"SL Pond","year":"2005","journal-title":"Bioinformatics"},{"key":"ref91","first-page":"715","article-title":"A likelihood approach for comparing synonymous and nonsynonymous nucleotide substitution rates, with application to the chloroplast genome.","volume":"11","author":"SV Muse","year":"1994","journal-title":"Mol Biol Evol"},{"key":"ref92","first-page":"452","article-title":"Estimating selection pressures on aligments of coding sequences: practice.","author":"SL Kosakovsky Pond","year":"2009"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/molbev\/msi105","article-title":"Not so different after all: a comparison of methods for detecting amino acid sites under selection.","volume":"22","author":"SL Kosakovsky Pond","year":"2005","journal-title":"Mol Biol Evol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/molbev\/msi232","article-title":"Site-to-site variation of synonymous substitution rates.","volume":"22","author":"SK Pond","year":"2005","journal-title":"Mol Biol Evol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","article-title":"The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.","volume":"22","author":"K Arnold","year":"2006","journal-title":"Bioinformatics"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"D387","DOI":"10.1093\/nar\/gkn750","article-title":"The SWISS-MODEL Repository and associated resources.","volume":"37","author":"F Kiefer","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt0795-658","article-title":"Protein Modeling by E-mail.","volume":"13","author":"MC Peitsch","year":"1995","journal-title":"Nature Biotechnology"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.","volume":"18","author":"N Guex","year":"1997","journal-title":"Electrophoresis"},{"key":"ref99","article-title":"Discovery Studio 2.1.","author":"Inc Accelrys","year":"2008"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera, a visualization system for exploratory research and analysis.","volume":"25","author":"EF Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1107\/S0108767391012680","article-title":"A Resolution-Sensitive Procedure for Comparing Protein Surfaces and its Application to the Comparison of Antigen-Combining Sites.","volume":"A48","author":"M Gerstein","year":"1992","journal-title":"Acta Cryst"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0014548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T23:00:04Z","timestamp":1685919604000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0014548"}},"subtitle":[],"editor":[{"given":"John J.","family":"Rossi","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2011,1,20]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,1,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0014548","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,20]]}}}